Biotage AB (publ)
BITGF · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -5.92 | 0.08 | -10.26 | 1.49 |
| FCF Yield | 0.12% | 0.95% | 0.40% | -0.07% |
| EV / EBITDA | 323.43 | 58.33 | 137.56 | 107.37 |
| Quality | ||||
| ROIC | -0.28% | 3.87% | 1.13% | -0.07% |
| Gross Margin | 62.86% | 61.86% | 61.84% | 64.29% |
| Cash Conversion Ratio | 10.75 | 1.03 | 1.79 | 0.50 |
| Growth | ||||
| Revenue 3-Year CAGR | 8.37% | 9.50% | 11.58% | 13.28% |
| Free Cash Flow Growth | -91.20% | 104.92% | 777.78% | -113.43% |
| Safety | ||||
| Net Debt / EBITDA | -6.50 | -0.83 | -1.08 | -0.52 |
| Interest Coverage | 0.00 | 10.34 | 16.45 | -0.45 |
| Efficiency | ||||
| Inventory Turnover | 0.33 | 0.48 | 0.38 | 0.38 |
| Cash Conversion Cycle | 306.36 | 209.48 | 272.05 | 278.54 |